|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 37/04 | (2006.01) |
| (11) | Number of the document | 1372696 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01952420.6 |
| Date of filing the European patent application | 2001-07-02 | |
| (97) | Date of publication of the European application | 2004-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2008-07-23 |
| (46) | Date of publication of the claims translation | 2008-11-25 |
| (86) | Number | PCT/US2001/021204 |
| Date | 2001-07-02 |
| (87) | Number | WO 2002/002638 |
| Date | 2002-01-10 |
| (30) | Number | Date | Country code |
| 215913 P | 2000-07-03 | US |
| (72) |
COHEN, Robert, US
CARR, Suzette, US
HAGERTY, David, US
PEACH, Robert, J., US
BECKER, Jean-Claude, US
|
| (73) |
Bristol-Myers Squibb Company,
P.O. Box 4000, Lawrenceville-Princeton Road, Princeton, NJ 08543,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Reumatinių ligų gydymo būdas, naudojant tirpią CTLA4 molekulę |
| METHODS FOR TREATING RHEUMATIC DISEASES USING A SOLUBLE CTLA4 MOLECULE |
| Payment date | Validity (years) | Amount | |
| 2020-06-26 | 347.00 EUR |